Rare diseases
Investigational molecules
Locations
Study of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment
PolandStudy comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery
PolandStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
PolandLong-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031
PolandStudy of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy
PolandStudy comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy
PolandStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
PolandStudy of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis
PolandComparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery
PolandStudy of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
PolandStudy of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer
PolandStudy of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
